1. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis
   Kai Liu et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
2. Noninvasive assessments of liver disease severity based on biomarkers
   Takako Inoue et al, 2023, Comprehensive Guide to Hepatitis Advances CrossRef
3. Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis
   Nobuharu Tamaki et al, 2024, Diagnostics CrossRef
4. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
   Takeshi Chida et al, 2024, Scientific Reports CrossRef
5. Derivation and validation of Transform equations to convert historical Enhanced liver fibrosis (ELF) scores to modern equivalents
   Matthew F.W. Gee et al, 2024, Clinica Chimica Acta CrossRef
6. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment
   Shinya Maekawa et al, 2024, Journal of the Formosan Medical Association CrossRef
7. Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
   Chun-Ting Ho et al, 2024, Clinical and Molecular Hepatology CrossRef
8. Non‐invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response
   Shola M. Richards et al, 2023, Liver International CrossRef
9. Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma
   Chun-Ting Ho et al, 2024, Clinical and Translational Gastroenterology CrossRef
10. Navigating Cirrhosis: A Comprehensive Review of Liver Scoring Systems for Diagnosis and Prognosis
    Palash S Kotak et al, 2024, Cureus CrossRef